{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:02:04Z","timestamp":1790337724006,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.dld.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:17:07Z","timestamp":1783163827000},"page":"1229-1233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 receptor agonists in pediatric obesity"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-5336","authenticated-orcid":false,"given":"Martina","family":"Abodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-0832","authenticated-orcid":false,"given":"Carlo V.","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mazzocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.06.010_bib0001","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.dld.2026.06.010_bib0002","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrneph.2017.123","article-title":"GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes","volume":"13","author":"Muskiet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.dld.2026.06.010_bib0003","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/jama.2024.18000","article-title":"GLP-1 for treating obesity-origin, history, and evolution: 2024 Lasker-DeBakey clinical medical research award","volume":"332","author":"Knudsen","year":"2024","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.dld.2026.06.010_bib0004","doi-asserted-by":"crossref","first-page":"9324","DOI":"10.3390\/ijms24119324","article-title":"Therapeutic mechanisms and clinical effects of glucagon-like peptide 1 receptor agonists in nonalcoholic fatty liver disease","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2026.06.010_bib0005","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamaoncol.2025.2681","article-title":"GLP-1 receptor agonists and cancer risk in adults with obesity","volume":"11","author":"Dai","year":"2025","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.dld.2026.06.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-068119","article-title":"GLP-1 receptor agonists in pediatric and adolescent obesity","volume":"155","author":"Stefater-Richards","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.dld.2026.06.010_bib0007","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/jama.2025.13665","article-title":"Current and future medications for obesity treatment","volume":"334","author":"Kushner","year":"2025","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.dld.2026.06.010_bib0008","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jama.2025.14392","article-title":"New molecules and indications for GLP-1 medicines","volume":"334","author":"Gonzalez-Rellan","year":"2025","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.dld.2026.06.010_bib0009","first-page":"1512","article-title":"Obesity and mental health in childhood and adolescence: a scoping review of recent scientific evidence","volume":"12","author":"Morales-Su\u00e1rez-Varela","year":"2025","journal-title":"Children (Basel)"},{"key":"10.1016\/j.dld.2026.06.010_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jadohealth.2010.06.019","article-title":"Overweight and obesity between adolescence and young adulthood: a 10-year prospective cohort study","volume":"48","author":"Patton","year":"2011","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.dld.2026.06.010_bib0011","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa1703860","article-title":"Simulation of growth trajectories of childhood obesity into adulthood","volume":"377","author":"Ward","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2026.06.010_bib0012","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(25)00397-6","article-title":"Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2026.06.010_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/pedsos.2025-000623","article-title":"Shifts in US pediatric obesity treatment after the AAP guidelines","volume":"1","author":"Rodriguez","year":"2025","journal-title":"Pediatr Open Sci"},{"key":"10.1016\/j.dld.2026.06.010_bib0014","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapediatrics.2025.3327","article-title":"Ethics of lifestyle counsel alone in a GLP-1 era","volume":"179","author":"Stephenson","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.dld.2026.06.010_bib0015","article-title":"Executive summary: Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.dld.2026.06.010_bib0016","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2026.06.010_bib0017","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa2407379","article-title":"Liraglutide for children 6 to <12 years of age with obesity - A randomized trial","volume":"392","author":"Fox","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2026.06.010_bib0018","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2026.06.010_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2026.06.010_bib0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41390-025-04228-1","article-title":"GLP-1 receptor agonists for the treatment of obesity in children and adolescents: a meta-analysis of randomized controlled trials","volume":"99","author":"Romariz","year":"2026","journal-title":"Pediatr Res"},{"key":"10.1016\/j.dld.2026.06.010_bib0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12887-024-04646-w","article-title":"Family systems approaches in pediatric obesity management: a scoping review","volume":"24","author":"Wills-Ibarra","year":"2024","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.dld.2026.06.010_bib0022","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.3390\/jcm14113791","article-title":"Weight regain after liraglutide, semaglutide or tirzepatide interruption: a narrative review of randomized studies","volume":"14","author":"Quarenghi","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.dld.2026.06.010_bib0023","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.dld.2026.06.010_bib0024","article-title":"Rebound or retention: a meta-analysis of weight regain after the discontinuation of glucagon-like peptide-1 (GLP-1) receptor agonists and other anti-obesity drugs","volume":"17","author":"Kolli","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.dld.2026.06.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103680","article-title":"Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis","volume":"90","author":"Tzang","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.dld.2026.06.010_bib0026","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/MOP.0000000000001379","article-title":"Use of glucagon-like-peptide 1 receptor agonist in the treatment of childhood obesity","volume":"36","author":"Kavarian","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.dld.2026.06.010_bib0027","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamapediatrics.2024.3812","article-title":"Risk of suicidal ideation or attempts in adolescents with obesity treated with GLP1 receptor agonists","volume":"178","author":"Kerem","year":"2024","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.dld.2026.06.010_bib0028","first-page":"118","article-title":"Self-image, self-esteem and depression in children and adolescents with and without obesity","volume":"158","author":"S\u00e1nchez-Rojas","year":"2022","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.dld.2026.06.010_bib0029","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10408398.2020.1823813","article-title":"Association between overweight\/obesity with depression, anxiety, low self-esteem, and body dissatisfaction in children and adolescents: a systematic review and meta-analysis of observational studies","volume":"62","author":"Moradi","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.dld.2026.06.010_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s40519-024-01693-1","article-title":"Differences in body dissatisfaction between individuals with and without stigma toward obesity: a study of preadolescents and adolescents","volume":"29","author":"Amaya-Hern\u00e1ndez","year":"2024","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.dld.2026.06.010_bib0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/chi.2024.0317","article-title":"The unintended psychosocial consequences of GLP-1 receptor agonists for children and adolescents: a call for more research","volume":"21","author":"C\u00f4t\u00e9","year":"2025","journal-title":"Child Obes"},{"key":"10.1016\/j.dld.2026.06.010_bib0032","article-title":"Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: a call to action","volume":"7","author":"Cooper","year":"2023","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.dld.2026.06.010_bib0033","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cen.15133","article-title":"Anti-obesity medication in the management of children and adolescents with obesity: recent developments and research gaps","volume":"102","author":"Torbahn","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.dld.2026.06.010_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025545","article-title":"Racial and ethnic disparities in financial barriers among overweight and obese adults eligible for semaglutide in the United States","volume":"11","author":"Lu","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.dld.2026.06.010_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221090009","article-title":"Anti-obesity medication prescriptions by race\/ethnicity and use of an interpreter in a pediatric weight management clinic","volume":"13","author":"Bomberg","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.dld.2026.06.010_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/14574969241297517","article-title":"Metabolic and bariatric surgery for adolescents with severe obesity: benefits, risks, and specific considerations","volume":"114","author":"J\u00e4rvholm","year":"2025","journal-title":"Scand J Surg"},{"key":"10.1016\/j.dld.2026.06.010_bib0037","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41390-019-0532-3","article-title":"Short- and long-term safety and efficacy of bariatric surgery for severely obese adolescents: a narrative review","volume":"87","author":"Sarno","year":"2020","journal-title":"Pediatr Res"},{"key":"10.1016\/j.dld.2026.06.010_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.878202","article-title":"Short-term changes in mental, physical, and social factors after metabolic bariatric surgery in adolescents: a nationwide prospective cohort study","volume":"9","author":"Goldenshluger","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.dld.2026.06.010_bib0039","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12480","article-title":"Mental health of adolescents after bariatric surgery: a textual analysis","volume":"11","author":"Rigal","year":"2021","journal-title":"Clin Obes"},{"key":"10.1016\/j.dld.2026.06.010_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.soard.2024.09.003","article-title":"Psychosocial outcomes after adolescent metabolic and bariatric surgery: a narrative review of the literature","volume":"21","author":"Boles","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.dld.2026.06.010_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2025.114564","article-title":"Metabolic and bariatric surgery utilization in the era of glucagon-like peptide-1 receptor agonists among adolescents versus adults","volume":"282","author":"Messiah","year":"2025","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2026.06.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.13154","article-title":"An open-label 16-week study of liraglutide in adolescents with obesity post-sleeve gastrectomy","volume":"19","author":"Zenno","year":"2024","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.dld.2026.06.010_bib0043","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13256-025-05047-y","article-title":"Semaglutide and laparoscopic sleeve gastrectomy in an adolescent with congenital adrenal hyperplasia due to 21-hydroxylase: a case report","volume":"19","author":"Vidmar","year":"2025","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.dld.2026.06.010_bib0044","article-title":"Type 2 diabetes in a 4-year-old with obesity: considerations for use of semaglutide and bariatric surgery in children","volume":"3","author":"Connard","year":"2025","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.dld.2026.06.010_bib0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/CRD.0000000000000515","article-title":"Tirzepatide for weight loss: can medical therapy \u201coutweigh\u201d bariatric surgery?","volume":"31","author":"Novograd","year":"2023","journal-title":"Cardiol Rev"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:19:25Z","timestamp":1790335165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826007760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1590865826007760"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.06.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists in pediatric obesity","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}